Expression of L3MBTL4 level was decreased at least two-fold in 73% of breast cancer samples, particularly in tumors deleted at the L3MBTL4 locus since decreased expression correlated with genomic alteration. This evidence concerns the gene L3MBTL4 and breast cancer.